Monitoring HIV treatment in the developing world

Lancet Infect Dis. 2002 Nov;2(11):656-7. doi: 10.1016/s1473-3099(02)00435-8.
No abstract available

MeSH terms

  • Anti-HIV Agents / therapeutic use*
  • Antiretroviral Therapy, Highly Active / economics
  • CD4 Lymphocyte Count
  • Developing Countries*
  • HIV Core Protein p24 / blood
  • HIV Infections / drug therapy*
  • HIV Infections / economics
  • HIV Infections / immunology
  • Humans
  • Lymphocyte Count / economics
  • Lymphocyte Count / methods*
  • Monitoring, Immunologic
  • Treatment Outcome

Substances

  • Anti-HIV Agents
  • HIV Core Protein p24